summary
Introduced
01/06/2026
01/06/2026
In Committee
01/13/2026
01/13/2026
Crossed Over
Passed
Dead
Introduced Session
2026 Regular Session
Bill Summary
Create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to cover at least 2 medically necessary epinephrine devices per covered person; limit a covered person's cost-sharing amount to $100 annually; amend KRS 304.17A-099 to exempt the epinephrine device coverage requirement from being suspended under state law due to the triggering of federal cost defrayment requirements; amend KRS 205.522, 205.6485, 164.2871, and 18A.225 to require Medicaid, KCHIP, self-insured employer group health plans offered by the governing board of a state postsecondary education institution, and the state employee health plan to comply with the epinephrine device coverage requirement; provide that various sections apply to health benefit plans issued or renewed on or after January 1, 2027; require the Department of Insurance to determine whether the epinephrine devices coverage requirement would be in addition to essential health benefits required under federal law; require the Department of Insurance to obtain federal approval, if necessary; require the Cabinet for Health and Family Services or the Department for Medicaid Services to obtain federal approval, if necessary; provide authorization from the General Assembly to make changes in the Medicaid program as required under KRS 205.5372(1); EFFECTIVE, in part, January 1, 2027.
AI Summary
This bill requires health benefit plans, including those offered by Medicaid, the Kentucky Children's Health Insurance Program (KCHIP), self-insured employer plans at state postsecondary institutions, and the state employee health plan, to cover at least two medically necessary epinephrine devices per person annually, with a limit on out-of-pocket costs (cost-sharing) to $100 per year. An epinephrine device is a single-use tool for administering epinephrine, a medication used to treat severe allergic reactions. The bill also ensures that this new coverage requirement for epinephrine devices will not be suspended due to federal cost-sharing regulations and mandates that the Department of Insurance and the Cabinet for Health and Family Services or Department for Medicaid Services seek any necessary federal approvals to implement these changes, which will take effect for plans issued or renewed on or after January 1, 2027.
Committee Categories
Business and Industry
Sponsors (15)
Adam Moore (D)*,
Chad Aull (D),
Ryan Bivens (R),
George Brown (D),
Adrielle Camuel (D),
Beverly Chester-Burton (D),
Anne Donworth (D),
David Hale (R),
Erika Hancock (D),
J.T. Payne (R),
Rachel Roarx (D),
Pamela Stevenson (D),
Aaron Thompson (R),
Joshua Watkins (D),
Mitchum Whitaker (R),
Last Action
to Banking & Insurance (H) (on 01/13/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://apps.legislature.ky.gov/record/26RS/hb32.html |
| BillText | https://apps.legislature.ky.gov/recorddocuments/bill/26RS/hb32/orig_bill.pdf |
| Local Mandate Fiscal Impact | https://apps.legislature.ky.gov/recorddocuments/note/26RS/hb32/LM.pdf |
Loading...